Cedar Mountain Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37K | Hold |
5,651
| – | – | ﹤0.01% | 277 |
|
|
2025
Q1 | $3.11K | Hold |
5,651
| – | – | ﹤0.01% | 274 |
|
|
2024
Q4 | $5.16K | Hold |
5,651
| – | – | ﹤0.01% | 256 |
|
|
2024
Q3 | $4.92K | Hold |
5,651
| – | – | ﹤0.01% | 247 |
|
|
2024
Q2 | $5.59K | Hold |
5,651
| – | – | ﹤0.01% | 223 |
|
|
2024
Q1 | $5.99K | Hold |
5,651
| – | – | ﹤0.01% | 214 |
|
|
2023
Q4 | $7.63K | Hold |
5,651
| – | – | ﹤0.01% | 197 |
|
|
2023
Q3 | $12.3K | Hold |
5,651
| – | – | ﹤0.01% | 163 |
|
|
2023
Q2 | $14.7K | Hold |
5,651
| – | – | ﹤0.01% | 136 |
|
|
2023
Q1 | $6.78K | Hold |
5,651
| – | – | ﹤0.01% | 189 |
|
|
2022
Q4 | $9.21K | Hold |
5,651
| – | – | ﹤0.01% | 166 |
|
|
2022
Q3 | $7K | Hold |
5,651
| – | – | ﹤0.01% | 186 |
|
|
2022
Q2 | $6K | Hold |
5,651
| – | – | ﹤0.01% | 204 |
|
|
2022
Q1 | $9K | Hold |
5,651
| – | – | ﹤0.01% | 183 |
|
|
2021
Q4 | $8K | Hold |
5,651
| – | – | ﹤0.01% | 198 |
|
|
2021
Q3 | $12K | Hold |
5,651
| – | – | ﹤0.01% | 151 |
|
|
2021
Q2 | $16K | Hold |
5,651
| – | – | 0.01% | 132 |
|
|
2021
Q1 | $22K | Hold |
5,651
| – | – | 0.01% | 125 |
|
|
2020
Q4 | $13K | Hold |
5,651
| – | – | ﹤0.01% | 155 |
|
|
2020
Q3 | $10K | Hold |
5,651
| – | – | ﹤0.01% | 161 |
|
|
2020
Q2 | $11K | Hold |
5,651
| – | – | ﹤0.01% | 143 |
|
|
2020
Q1 | $8K | Hold |
5,651
| – | – | ﹤0.01% | 135 |
|
|
2019
Q4 | $27K | Buy |
+5,651
| New | +$27K | 0.01% | 89 |
|